Document:

Summary of Director Compensation

 EXHIBIT 10.6 
 ICAGEN, INC. 
 Summary of Director Compensation 
 Compensation of our Directors 
 Icagen, Inc.
reimburses each non-employee director for out-of-pocket expenses they incur in attending Board and committee meetings and pays each non-employee director an annual retainer fee of $25,000. The Chairman of the Company’s Audit Committee receives
an additional annual retainer of $10,000 and other committee chairmen receive an additional annual retainer of $3,000. In addition, the Company pays each non-employee director $1,000 for attendance at each Board meeting in which he or she
participates in person or $500 if attendance is by telephone. Each non-employee director also receives $1,000 for each meeting of a committee of the Board in which he or she participates in person or $500 if attendance is by telephone that is held
on a day other than the day of the date of any meeting of the full Board of Directors. Directors who are also the Company’s employees do not receive any compensation in their capacities as directors. 
 Each of the Company’s non-employee directors receives options to purchase 25,000 shares of the Company’s common stock for his or her services
as a director for each three-year term served. Options for the Company’s current directors are granted every three calendar years as of the first business day of the calendar year. Options for new directors will be granted as of the date of the
election or appointment of the director to the Board of Directors. Options granted to the non-employee directors vest monthly over three years, subject to the director’s continued service as a director. In addition, the Company’s Chairman
of the Board of Directors receives options to purchase 20,000 additional shares of the Company’s common stock for his or her services as a director for each year served. Options for the Company’s Chairman of the Board of Directors are
granted every calendar year as of the first business day of the calendar year. Options granted to the Chairman of the Board of Directors vest monthly over one year, subject to the director’s continued service as a director. Options granted to
non-employee directors have exercise prices equal to the fair market value of common stock at the date of grant.Summary of 2007 Bonus Targets

 EXHIBIT 10.7 
 ICAGEN, INC. 
 Summary of 2007 Bonus Targets 
 Executive Officer 2007 Bonus Targets 
  

			
	 Executive Officer
	  	 Bonus Targets for 2007

		
	P. Kay Wagoner, Ph.D., Chief Executive Officer and President	  	Up to 30% of base salary
		
	Richard D. Katz, M.D., Senior Vice President, Finance and Corporate Development, Chief Financial Officer and Treasurer	  	Up to 30% of base salary
		
	Edward P. Gray, J.D., Senior Vice President, Intellectual Property, Chief Patent Counsel and Secretary	  	Up to 30% of base salary
		
	Seth V. Hetherington, Senior Vice President, Clinical and Regulatory Affairs	  	Up to 30% of base salary

 Target bonuses for Dr. Wagoner, Dr. Katz, Mr. Gray and Dr. Hetherington for 2007 will be based
on the achievement of specified corporate performance objectives and, in the case of Dr. Wagoner, individual performance objectives. The corporate performance objectives include progression of preclinical and clinical development programs,
increasing awareness of Icagen within the investment community, achievement of corporate and business development objectives, timely, effective and efficient completion of public company reporting obligations, completing and maintaining policies and
procedures for internal controls and compliance obligations and further developing the Company’s intellectual property portfolio to build value in a cost-effective manner. 80% of Dr. Wagoner’s target bonus will be based on corporate
performance objectives as described above and 20% of her target bonus will be based on individual performance objectives. Dr. Wagoner’s individual performance objectives include strengthening Icagen’s management team, especially in
the areas of research and development and general and administrative, and assisting the Nominating/Corporate Governance Committee in the continual development of high performance standards for Icagen’s board of directors and its committees.Amendment to Mr. Tolworthy's Employment Agreement, dated February 28, 2007

 Exhibit 10.30 
 

 
 February 28, 2007 
  

			
	 To:
	  	Thomas Tolworthy
		
	 Re:
	  	 Third Amended and Restated Employment and
 Non-Competition Agreement dated June 12, 2006

 Tom: 
 On behalf of
the Board of Directors of VS Parent, Inc., a Delaware corporation, VS Holdings, Inc., a Delaware corporation (“Holdings”), and Vitamin Shoppe Industries Inc., a New York corporation (“Company”), I am writing to memorialize the
changes that have been agreed upon with respect to your employment relationship. 
 We have agreed to the following changes to the above-referenced agreement
(the “Third Amendment”). Capitalized terms not otherwise defined herein shall have the meanings set forth in the Third Amendment: 
 1. The Initial Term is hereby extended so that the same shall terminate eight (8) years after the Original Effective Date, or November 26, 2010, subject to annual renewal as set forth in Section 3 of the Third Amendment.

 2. Section 3 of the Third Amendment is hereby amended by deleting the phrase “not later than six (6) months prior to the
end of the Initial Term” in its entirety and substituting the following in its stead: “not later than twelve (12) months prior to the end of the Initial Term”. 
 3. For fiscal year 2007 your Annual Cash Bonus shall be based upon Vitamin Shoppe’s EBITDA as reflected in the audited financial statements for the
year. If the EBITDA is below $50.3 million, you will not receive any Annual Cash Bonus for 2007. If the EBITDA is $58.6 million or more, you shall receive an Annual Cash Bonus equal to one hundred twenty percent (120%) of your Base Salary for
the 2007 fiscal year. Between such EBITDA numbers, you shall receive an Annual Cash Bonus as follows: 
 2101 91st Street · North Bergen, NJ 07047 
 Telephone: 201-868-5959
· Fax: 201-868-0727 · www.vitaminshoppe.com

 Mr. Thomas Tolworthy 
 February 28, 2007 
 Page 2 
  

				
	 EBITDA
 (Millions)
	  	Annual Cash Bonus as a
Percentage of Base Salary	 
	 $50.3
	  	25	%
	   55.3
	  	100	%
	   58.6
	  	120	%

 Between the three EBITDA targets set forth above ($50.3, $55.3 and $58.6), there will be a straight line
interpolation. For example, if the EBITDA for fiscal 2007 is $54.3 million, you will have earned an Annual Cash Bonus equal to 85% of your Base Salary. All Annual Cash Bonus calculations shall be rounded to the nearest percent. 
 If the foregoing accurately represents your understanding of our agreement, please sign a copy of this letter and return the same to me. 
  

			
	VS Parent, Inc.
	VS Holdings, Inc.
	Vitamin Shoppe Industries Inc.
		
	By:	 	 /s/ Douglas Korn

		 	Douglas Korn, Chairman of the Compensation
		 	Committee of the Board of Directors of VS
		 	Parent, Inc.
	
	 AGREED AND ACCEPTED AS OF THIS
 2nd DAY OF MARCH, 2007

		
	By:	 	 /s/ Thomas Tolworthy

		 	Thomas Tolworthy
		 	Chief Executive OfficerAmendment No. 1 to Dealer Manager Agreement

 Exhibit 10.1 
 PALADIN REALTY INCOME PROPERTIES INC. 
 AMENDMENT TO DEALER MANAGER AGREEMENT 
 February 28, 2007 
 Prospect Financial Advisors, LLC

 11355 West Olympic Boulevard, Suite 220 
 Los Angeles, CA 90064

 Ladies and Gentlemen: 
 Paladin Realty Income
Properties, Inc., a Maryland corporation (the “Company”), Paladin Realty Income Properties, L.P., a Delaware limited partnership (the “Operating Partnership”), Paladin Realty Advisors, LLC, a Delaware limited
liability company (the “Advisor”) and Prospect Financial Advisors, LLC, a Delaware limited liability company (the “Dealer Manager”) previously entered into that certain Dealer Manager Agreement dated
February 28, 2005 (the “Agreement”). The Company, the Operating Partnership, the Advisor and the Dealer Manager are sometimes hereinafter referred to individually as a “party” or collectively as the
“parties.” 
 The parties hereby acknowledge and agree that the term of the Agreement shall expire on February 28, 2007. The
parties wish to extend the term of the Agreement, on the terms and conditions set forth in this letter (the “Amendment”), on a “non-exclusive” basis. All terms not defined herein shall have the same meaning as in the
Agreement. Except as specifically set forth in this Amendment, all terms and conditions of the Agreement shall remain in full force and effect. 
 The Company, the Operating Partnership, the Advisor and the Dealer Manager hereby jointly and severally agree as follows: 
 1.
Obligations and Compensation of Dealer Manager. Section 4.1 of the Agreement is hereby amended to read in its entirety as follows: 
 “4.1.(a) The Company hereby appoints the Dealer Manager as its exclusive agent and distributor during the period commencing with the Effective Date and ending on February 28, 2007 (the “Offering Period”) to
solicit and to cause Participating Dealers to solicit subscriptions for the Offered Shares at the subscription price to be paid in accordance with, and otherwise upon the other terms and conditions set forth in, the Prospectus and the Subscription
Agreement, and the Dealer Manager agrees to use its best efforts to procure subscribers for the Offered Shares during the Offering Period. The Offered Shares offered and sold through the Dealer Manager under this Agreement shall be offered and sold
only by the Dealer Manager and, at the Dealer Manager’s sole option, by any Participating Dealers whom the Dealer Manager may retain, each of which shall be members of the NASD in good standing, pursuant to an executed Dealer Agreement with
such Participating Dealer. The Dealer Manager hereby accepts such agency and distributorship 

 
and agrees to use its best efforts to sell the Shares on said terms and conditions. Notwithstanding the foregoing, commencing on February 28, 2007, the
Dealer Manager’s obligations under this Agreement shall consist of acting as the “non-exclusive” agent of the Company, at the same rate of compensation provided under Section 4.5 and reimbursement of costs and expenses provided
under Section 3, for the sole purpose of assisting Participating Dealers in processing subscriptions. 
 (b) The Dealer Manager
represents to the Company that (i) it is a member of the NASD in good standings, (ii) it and its employees and representatives have all required licenses and registrations to act under this Agreement and (iii) it has established and
implemented anti-money laundering compliance programs in accordance with applicable law, including applicable NASD rules, Commission rules and regulations and the USA PATRIOT Act of 2001, reasonably expected to detect and cause the reporting of
suspicious transactions in connection with the offering and sale of the Offered Shares.” 
 2. Term and Termination. 

(a) Section 11.2 of the Agreement is hereby amended to read, in its entirety, as follows: 
 “11.2 The Dealer Manager, upon the expiration or termination of this Agreement, shall (i) promptly deposit any and all funds, if any, in its
possession which were received from investors for the sale of Offered Shares into the appropriate escrow account, (ii) promptly deliver to the Company all records and documents in its possession which relate to the Offering and are not
designated as dealer copies, (iii) provide a list of all purchasers and broker-dealers with whom the Dealer Manager has initiated oral or written discussions regarding the Offering (the “Termination List”), and (iv) notify
Participating Dealers of such termination. The Dealer Manager, at its sole expense, may make and retain copies of all such records and documents, but shall keep all such information confidential. Upon a termination of this Agreement on or after
May 31, 2007, the Dealer Manager shall use its reasonable efforts to cooperate with the Company to accomplish an orderly transfer of management of the Offering to a party designated by the Company.” 
 (b) Section 11 of the Agreement is hereby amended by the addition of new subparagraph 11.4 to read, in its entirety, as follows: 
 “11.4. This Agreement (i) may be terminated, commencing on and after May 31, 2007, by either the Company or the Dealer Manager, with or
without cause, upon thirty (30) days prior written notice to the other party and (ii) shall terminate immediately upon the effective date of the appointment by the Company of an “exclusive” agent and distributor to assume and/or
perform the rights, duties and obligations of the Dealer Manager under this Agreement. In consideration of the Dealer Manager’s agreement to extend the term of the Agreement, on a non-exclusive basis, beyond February 28, 2007, each of the
Company, the Operating Partnership and the Advisor (collectively, the “Releasors”) hereby irrevocably and unconditionally releases and forever discharges the Dealer Manager from any and all claims, demands, liabilities, suits or
damages of any type or kind, whether in law or in equity, known or unknown, suspected or unsuspected, of any type or nature which the Releasors, either jointly or severally, may have or may in the future have against the Dealer Manager, including
any obligations of the Dealer Manager under Section 5.2, resulting from, arising out of or in 

 
connection with any event, act, omission or circumstance occurring or prevailing up to and including February [28], 2007. Upon termination of this Agreement,
in consideration of the Dealer Manager’s cooperation to accomplish an orderly transfer of management of the Offering to a party designated by the Company, including assignment by the Dealer Manager of its rights, duties and obligations under
Participating Dealer Agreements, each of the Releasors hereby covenants and agrees that it shall also execute a general release in the form set forth in this Section 11.4, which general release shall be effective for the period up to and
including the date of termination of this Agreement. The Releasors hereby acknowledge and agree that the foregoing covenant to provide such general release upon termination is a material inducement to the Dealer Manager’s agreement to extend
the term of the Agreement. Each of the Releasors hereby waives and relinquishes all rights and benefits afforded by California Civil Code Section 1542 (“Section 1542”) and does so understanding and acknowledging the
significance and consequences of the specific waiver of Section 1542. Section 1542 states as follows: 
 A GENERAL RELEASE DOES
NOT EXTEND TO CLAIMS WHICH THE CREDITOR DOES NOT KNOW OR SUSPECT TO EXIST IN HIS FAVOR AT THE TIME OF EXECUTING THE RELEASE, WHICH IF KNOWN BY HIM MUST HAVE MATERIALLY AFFECTED HIS SETTLEMENT WITH THE DEBTOR.” 
 [Signature Page Follows] 

 If the foregoing correctly sets forth our understanding, please indicate your acceptance thereof in the
space provided below for that purpose, whereupon this Amendment and your acceptance shall constitute a binding agreement between us as of the date first above written. 
  

			
	PALADIN REALTY INCOME PROPERTIES, INC.
		
	By:	 	 /s/ Michael Lenard

	Name:	 	Michael Lenard
	Title:	 	Executive Vice President
	
	PALADIN REALTY INCOME PROPERTIES, L.P.
		
	By:	 	 /s/ Michael Lenard

	Name:	 	Michael Lenard
	Title:	 	Executive Vice President
	
	PALADIN REALTY ADVISORS, LLC
		
	By:	 	 /s/ Michael Lenard

	Name:	 	Michael Lenard
	Title:	 	Executive Vice President

 Accepted and agreed as of the date first above written: 
  

			
	PROSPECT FINANCIAL ADVISORS, LLC
		
	By:	 	 /s/ Scott E. Wendelin

	Name:	 	Scott E. Wendelin
	Title:	 	Senior Managing Director and CEO

Source: [{"source": "alea-institute/alea-institute/kl3m-data-edgar-agreements/train-00118-of-00352.parquet"}, [{"source": "alea-institute/alea-institute/kl3m-data-edgar-agreements/train-00118-of-00352.parquet"}], [{"source": "alea-institute/alea-institute/kl3m-data-edgar-agreements/train-00118-of-00352.parquet"}], [{"source": "alea-institute/alea-institute/kl3m-data-edgar-agreements/train-00118-of-00352.parquet"}]]